Literature DB >> 9510860

Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC.

T Dervieux1, R Boulieu.   

Abstract

6-thioguanine (6-TGN) and methyl 6-mercaptopurine nucleotides (Me6-MPNs) are the two major metabolites found in erythrocytes after administration of azathioprine. In an attempt to understand the role of these metabolites in the pharmacologic and toxic activity of thiopurines, we have developed a HPLC method for the simultaneous determination of 6-TGNs and Me6-MPNs in erythrocytes. A simple and rapid treatment procedure based on deproteinization by perchloric acid with dithiothreitol is described. The nucleotides were hydrolyzed to their own bases by heating the sample for 45 min at 100 degrees C. During acid hydrolysis Me6-MP was converted into a compound analyzed on a Purospher RP18-e column with 0.02 mol/L dihydrogenophosphate buffer-methanol as eluents. With this procedure, mean recoveries of 73.1% and 84.0% for 6-TGN and Me6-MPN derivatives, respectively, were found.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510860

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  29 in total

1.  Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.

Authors:  Gabriele Stocco; Eva Cuzzoni; Sara De Iudicibus; Diego Favretto; Noelia Malusà; Stefano Martelossi; Elena Pozzi; Paolo Lionetti; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?

Authors:  Luc J J Derijks; Daniel W Hommes
Journal:  Curr Gastroenterol Rep       Date:  2006-04

3.  Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse.

Authors:  Gabriele Stocco; Stefano Martelossi; Noelia Malusa'; Sara Marino; Giuliana Decorti; Fiora Bartoli; Alessandro Ventura
Journal:  Dig Dis Sci       Date:  2008-05-10       Impact factor: 3.199

4.  Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study.

Authors:  Kristyna Pospisilova; Jitka Siroka; Eva Karaskova; Ondrej Hradsky; Tereza Lerchova; Kristyna Zarubova; Ivana Copova; Lucie Gonsorcikova; Maria Velganova-Veghova; Irena Francova; Lubor Urbanek; Milos Geryk; Vladimir Mihal; Jiri Bronsky
Journal:  Paediatr Drugs       Date:  2021-03-11       Impact factor: 3.022

Review 5.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

6.  Correlation of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentration in Han Chinese patients treated with azathioprine 25 to 100 mg: A 1-year, single-center, prospective study.

Authors:  Bo Zhang; Xiao-Wei Xu; Xue-Jun Zeng; Da-Kui Li
Journal:  Curr Ther Res Clin Exp       Date:  2006-07

7.  Thioguanine in inflammatory bowel disease: Long-term efficacy and safety.

Authors:  Mark G Ward; Kamal V Patel; Viraj C Kariyawasam; Rishi Goel; Ben Warner; Tim R Elliott; Paul A Blaker; Peter M Irving; Anthony M Marinaki; Jeremy D Sanderson
Journal:  United European Gastroenterol J       Date:  2016-08-01       Impact factor: 4.623

8.  Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.

Authors:  Rikke B Holmstrøm; Ditte V Mogensen; Jørn Brynskov; Mark A Ainsworth; Jacob Nersting; Kjeld Schmiegelow; Casper Steenholdt
Journal:  Dig Dis Sci       Date:  2018-03-21       Impact factor: 3.199

9.  Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia.

Authors:  B M de Oliveira; M B Viana; C L Zani; A J Romanha
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

10.  Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity.

Authors:  Lene O Reuther; Ben Vainer; Jesper Sonne; Niels-Erik Larsen
Journal:  Eur J Clin Pharmacol       Date:  2003-11-22       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.